Our Research
Cancerous cells accumulate numerous harmful genetic aberrations, yet they can override normal cellular checkpoints and continuously proliferated. They seem to do so, in part, by taking advantage of cellular recovery pathways. We aim to identify new pathways that cancers rely on for survival, with the ultimate goal of providing new anti-cancer therapeutic logistics.
Maintenance of genomic integrity is essential for all life forms. Loss of genomic integrity can lead to various abnormalities, including cell death, aging, and cancers. Understanding the molecular processes that preserve genomic integrity is important in biological and clinical sciences.
Cancers develop therapy resistance via multiple mechanisms. Some of these refractory cancers may rely on heightened activites of genomic-stabilizing pathways. We use synthetic lethality approaches to identify new genetic dependencies of cancers.
We employ a range of experimental tools to decipher funcional and structural features of genomic-stabilizing factors. These information may provide new avenues for anti-cancer strategies.
Research Tools